Harout Semerjian: It was an honor to be appointed to the Biotechnology Innovation Organization’s Board of Directors, Emerging Companies Section

Harout Semerjian, President and CEO at GlycoMimetics, posted on LinkedIn:

“It was an honor this week to be appointed to the Biotechnology Innovation Organization’s (BIO) Board of Directors, Emerging Companies Section. Our sector has the opportunity and responsibility to engage stakeholders as we advance innovation to improve the lives of patients. Dialogue is critical to overcoming the challenges we face in delivering on the promise of our unique mission.

A special shoutout to the incredible CEOs who welcomed me and shared their inspiring stories. Thankfully, we have leaders with resilience and grit, who advance their programs in challenging capital markets with grace and a smile!”

Source: Harout Semerjian/LinkedIn